| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/13/2011 | EP2342229A1 Pd-1 specific antibodies and uses thereof |
| 07/13/2011 | EP2342228A1 Pd-1 specific antibodies and uses thereof |
| 07/13/2011 | EP2342220A1 Methods and systems for predicting misfolded protein epitopes |
| 07/13/2011 | EP2342205A1 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
| 07/13/2011 | EP2342200A2 Compounds which selectively modulate the cb2 receptor |
| 07/13/2011 | EP2342199A2 Compounds which selectively modulate the cb2 receptor |
| 07/13/2011 | EP2341939A2 Dendritic cell modulatory molecule |
| 07/13/2011 | EP2341937A1 Composition for treating disease |
| 07/13/2011 | EP2341934A2 Methods to reduce b-helper t cells to treat autoimmune diseases |
| 07/13/2011 | EP2341914A2 Modulation of toll-like receptor 3 expression by antisense oligonucleotides |
| 07/13/2011 | EP2341897A2 Nanoparticles for immunotherapy |
| 07/13/2011 | EP1714976B1 Amino acid sequences from active principle of musk and their acetic salt, also the preparation and usage |
| 07/13/2011 | EP1509489B1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 07/13/2011 | EP1486491B1 Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 07/13/2011 | EP1178825B1 Adjuvant combination formulations |
| 07/13/2011 | EP0979080B1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/13/2011 | CN1353609B Amide substituted imidazoquinolines |
| 07/13/2011 | CN102123995A Phenyl-alkyl piperazines having a modulating activity of tnf |
| 07/13/2011 | CN102123986A Pharmaceutical compositions |
| 07/13/2011 | CN102123735A Agent for induction/maintenance of remission |
| 07/13/2011 | CN102123717A Methods of treating inflammatory colon diseases |
| 07/13/2011 | CN102123715A Immune system stimulating nutrition |
| 07/13/2011 | CN102123709A A3 adenosine receptor allosteric modulators |
| 07/13/2011 | CN102123699A Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 07/13/2011 | CN102121021A cDNA of interferon (IFN)-gamma inducible lysosomal thiol reductase of sheep, cloning method and recombinant application thereof |
| 07/13/2011 | CN102121014A Xenopus tropicalis interleukin 8 cDNA, cloning method and recombination application thereof |
| 07/13/2011 | CN102121012A Dog B lymphocyte activating factor cDNA, cloning method and recombination application thereof |
| 07/13/2011 | CN102121011A B lymphocyte and proliferation-inducing ligand cDNA from danio rerio, cloning method and recombinant application thereof |
| 07/13/2011 | CN102121010A Takifugu obscures B lymphocyte stimulating factor cDNA and cloning method and recombination application thereof |
| 07/13/2011 | CN102120952A Health wine with functions of nourishing yin and tonifying yang |
| 07/13/2011 | CN102120773A Dual specificity antibodies and methods of making and using |
| 07/13/2011 | CN102120038A Gene treatment medicament capable of inhabiting immunoreaction caused by transgenosis products and preparation method thereof |
| 07/13/2011 | CN102120027A Composition of ciclosporin A and amphipathic chitosan derivatives and preparation thereof |
| 07/13/2011 | CN102119944A Dammarane type glycoside composition particles |
| 07/13/2011 | CN102119923A Antibiotic oil-water double suspension type injection emulsion for livestock and preparation method thereof |
| 07/13/2011 | CN101518644B Application of Ang-2 and genes thereof in pharmacy |
| 07/13/2011 | CN101084936B Method for preparing ginkgo leaves extraction |
| 07/12/2011 | US7977464 Antibody molecules specific to human tumour necrosis factor alpha |
| 07/12/2011 | US7977366 Treating an inflammatory disorder or inhibiting respiratory burst in adherent neutrophils with chemical inhibitors of neutrophil activation |
| 07/12/2011 | US7977350 CCR1 antagonists and methods of use therefor |
| 07/12/2011 | US7977344 Compounds |
| 07/12/2011 | US7977316 Prevention and treatment of amyloidogenic diseases |
| 07/12/2011 | US7977065 Yeast strains autonomously producing steroids |
| 07/12/2011 | US7977045 Aqueous-based pharmaceutical composition |
| 07/12/2011 | US7976840 Use of anti-GL50 antibodies for the downmodulation of an immune response |
| 07/12/2011 | US7975690 Nasal devices |
| 07/12/2011 | CA2524394C Novel benzodiazepine compounds, compositions and uses thereof |
| 07/12/2011 | CA2497167C Modified saccharides, conjugates thereof, and their manufacture |
| 07/12/2011 | CA2481767C Severe sepsis preventive therapeutic agent |
| 07/12/2011 | CA2463616C Affinity enhancement agents |
| 07/12/2011 | CA2458455C Pharmaceutical compositions comprising colloidal silicon dioxide |
| 07/12/2011 | CA2449150C Tricyclic compounds useful as angiotensin ii agonists |
| 07/12/2011 | CA2406570C Dermal compositions containing coenzyme q as the active ingredient |
| 07/12/2011 | CA2393312C Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 07/12/2011 | CA2389685C Novel heterocyclic compounds and their use as medicaments |
| 07/07/2011 | WO2011082400A2 Modulators of immunoinhibitory receptor pd-1, and methods of use thereof |
| 07/07/2011 | WO2011081523A1 Interferon analogs |
| 07/07/2011 | WO2011081489A2 Composition for treating allergic diseases, using wheat bran extract or active ingredient isolated therefrom |
| 07/07/2011 | WO2011081189A1 Anti-iga1 antibody |
| 07/07/2011 | WO2011081173A1 Tetracyclic compound |
| 07/07/2011 | WO2011080825A1 Anti-allergic agent |
| 07/07/2011 | WO2011079627A1 Multi-component adjuvant of immersion vaccine for fish, and its application and using method |
| 07/07/2011 | WO2011079507A1 Use of pacitaxel and docetaxel |
| 07/07/2011 | WO2010136766A3 Use of nlee for the treatment of autoimmune and inflammatory disorders, targetting nf - kappa b |
| 07/07/2011 | WO2010057275A8 Cyclic peptides and uses thereof |
| 07/07/2011 | US20110166218 Methods for micronization of hydrophobic drugs |
| 07/07/2011 | US20110166198 Rna compositions for modulating immune response |
| 07/07/2011 | US20110166174 Compounds modulating c-kit and c-fms activity and uses therefor |
| 07/07/2011 | US20110166168 Sulphone-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments |
| 07/07/2011 | US20110166159 Compounds that modulate intracellular calcium |
| 07/07/2011 | US20110166151 Glucocorticoid receptor agonist comprising 1,2,3,4-tetrahydroquinoxaline derivatives containing phenyl group having sulfonic acid ester structure introduced therein as substituent |
| 07/07/2011 | US20110166140 Novel sulphonylpyrroles |
| 07/07/2011 | US20110166130 Novel potassium channel blockers and uses thereof |
| 07/07/2011 | US20110166124 Tricyclic spirocycle derivatives and methods of use |
| 07/07/2011 | US20110166110 Fused Ring Azadecalin Glucocorticoid Receptor Modulators |
| 07/07/2011 | US20110166103 Boron-containing small molecules |
| 07/07/2011 | US20110166093 Use of adenosine receptor agonists in therapy |
| 07/07/2011 | US20110166084 Controlled release composition and method of producing the same |
| 07/07/2011 | US20110166080 Deuterated cyclosporine analogs and methods of making the same |
| 07/07/2011 | US20110166072 Polypeptides Selective for avB3 Integrin, Including Pegylated Polypeptides, And Pharmaceutical Uses Thereof |
| 07/07/2011 | US20110166071 Method for synthesizing thymosins |
| 07/07/2011 | US20110166058 Organic compositions to treat hsf1-related diseases |
| 07/07/2011 | US20110165633 Production of Polyketides and Other Natural Products |
| 07/07/2011 | US20110165272 Antiallergic composition |
| 07/07/2011 | US20110165256 Compositions and methods for treatment of hyperplasia |
| 07/07/2011 | US20110165230 Attenuated live vaccines |
| 07/07/2011 | US20110165224 Vaccines for inclusion body hepatitis |
| 07/07/2011 | US20110165223 Antitumor Immunization by Liposomal Delivery of Vaccine to the Spleen |
| 07/07/2011 | US20110165197 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 07/07/2011 | US20110165193 Methods for producing vaccine adjuvants |
| 07/07/2011 | US20110165190 Compositions and Methods for Immunizing Against Immunodeficiency Viruses |
| 07/07/2011 | US20110165189 Rabies virus-based recombinant immunocontraceptive compositions and methods of use |
| 07/07/2011 | US20110165188 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/07/2011 | US20110165187 Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines |
| 07/07/2011 | US20110165185 Immunogenic peptides |
| 07/07/2011 | US20110165181 Relay vaccine |
| 07/07/2011 | US20110165180 Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses |
| 07/07/2011 | US20110165177 Methods of Modulating Immunity |
| 07/07/2011 | US20110165169 Complement inhibitors and uses thereof |
| 07/07/2011 | US20110165165 Mammalian genes; related reagents and methods |